- Home
- UNCY vs CNVS Comparison
UNCY vs CNVS Comparison
Compare UNCY & CNVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UNCY
- CNVS
- Stock Information
- Founded
- UNCY 2016
- CNVS 2000
- Country
- UNCY United States
- CNVS United States
- Employees
- UNCY N/A
- CNVS N/A
- Industry
- UNCY Biotechnology: Pharmaceutical Preparations
- CNVS Consumer Electronics/Video Chains
- Sector
- UNCY Health Care
- CNVS Consumer Discretionary
- Exchange
- UNCY Nasdaq
- CNVS Nasdaq
- Market Cap
- UNCY 74.2M
- CNVS 64.1M
- IPO Year
- UNCY 2021
- CNVS 2003
- Fundamental
- Price
- UNCY $4.42
- CNVS $2.56
- Analyst Decision
- UNCY Strong Buy
- CNVS Buy
- Analyst Count
- UNCY 5
- CNVS 2
- Target Price
- UNCY $41.60
- CNVS $9.50
- AVG Volume (30 Days)
- UNCY 459.6K
- CNVS 114.7K
- Earning Date
- UNCY 11-14-2025
- CNVS 11-14-2025
- Dividend Yield
- UNCY N/A
- CNVS N/A
- EPS Growth
- UNCY N/A
- CNVS N/A
- EPS
- UNCY N/A
- CNVS 0.13
- Revenue
- UNCY N/A
- CNVS $80,173,000.00
- Revenue This Year
- UNCY N/A
- CNVS $0.76
- Revenue Next Year
- UNCY $19,392.60
- CNVS N/A
- P/E Ratio
- UNCY N/A
- CNVS $19.69
- Revenue Growth
- UNCY N/A
- CNVS 77.07
- 52 Week Low
- UNCY $3.71
- CNVS $2.24
- 52 Week High
- UNCY $11.00
- CNVS $7.39
- Technical
- Relative Strength Index (RSI)
- UNCY 43.93
- CNVS 22.02
- Support Level
- UNCY $4.32
- CNVS $2.85
- Resistance Level
- UNCY $4.63
- CNVS $2.88
- Average True Range (ATR)
- UNCY 0.29
- CNVS 0.15
- MACD
- UNCY -0.08
- CNVS -0.02
- Stochastic Oscillator
- UNCY 12.61
- CNVS 9.10
About UNCY Unicycive Therapeutics Inc.
Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's manufactures drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury. Company's pipeline comprised of two product candidates: Oxylanthanum Carbonate and UNI-494.
About CNVS Cineverse Corp.
Cineverse Corp is a main streaming technology and entertainment company. Its core business operates as a portfolio of owned and operated streaming channels with enthusiast fan bases; a large-scale aggregator and full-service distributor of feature films and television programs; and a proprietary technology software-as-a-service platform for over-the-top (OTT) app development and content distribution through subscription video-on-demand (SVOD), dedicated ad-supported (AVOD), ad-supported streaming linear (FAST) channels, social video streaming services, and audio podcasts. It generates revenue from streaming and digital, Base distribution, Podcast and other, and Other non-recurring.